Clinical Trial: CPG 7909 in Patients With Cutaneous T-Cell Lymphoma

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Phase I/II Open Label, Multi-Center Study For The Evaluation Of Pf-3512676 (CPG 7909) In Patients With Stage Ib To Iva Cutaneous T-Cell Lymphoma

Brief Summary: To assess the effect of CPG 7909 Injection on Cutaneous T-cell lymphoma and the safety of CPG 7909 Injection in patients with this cancer.